<DOC>
	<DOC>NCT02605928</DOC>
	<brief_summary>The study focuses on needle guidance in rheumatologic operations - glucocorticoid injections inside joint capsules specifically. The main purpose of the study is to assess and validate the clinical feasibility and performance of Bioimpedance Probe (BIP) Needles and assess the benefits, drawbacks and risks related to use of the BIP Needles.</brief_summary>
	<brief_title>Use of BIP-Needles in Rheumatologic Injections</brief_title>
	<detailed_description>Clinical device investigation</detailed_description>
	<criteria>Adult patients having an inflammatory rheumatic disease requiring an intraarticular glucocorticoid injection. Exclusion criteria are the same as generally for intraarticular glucocorticoid injections (e.g. bacterial infection or recent surgical operation relating the joint). In addition for not giving (or not capable to give) the consent personally for any reason is an absolute exclusion criterion. In addition pregnant women are excluded</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>Bioimpedance</keyword>
	<keyword>Glucocorticoid</keyword>
	<keyword>Intra-articular injection</keyword>
	<keyword>Needle Guidance</keyword>
</DOC>